Target intelligence / Profile preview

Infarct volume (None)

Target
None
Molecular classification
Other (not a molecule or receptor)
01

Overview

Infarct volume refers to the quantitative measurement of the amount of brain tissue that has undergone irreversible injury due to loss of blood supply following an acute ischemic event such as stroke. It is typically measured using neuroimaging techniques like MRI diffusion-weighted imaging or CT scans. Infarct volume serves as an objective surrogate marker for clinical outcome in both research and clinical trials on acute ischemic stroke therapies[1][2][3]. Larger final infarct volumes are strongly correlated with more severe neurological deficits and poorer functional recovery. Measurement methods include manual tracing on imaging slices, semiautomated software algorithms, or estimation formulas such as ABC/2[3][4]. The timing of measurement is important because early measurements may be confounded by edema; final assessment is usually performed at least 30 days post-stroke when the lesion stabilizes[1][2]. While crucial for evaluating treatment efficacy and prognosis in cerebrovascular disease studies, "infarct volume" itself does not represent a molecular entity or therapeutic target but rather an anatomical/radiological outcome variable.

Other names
Cerebral infarct volumeStroke lesion volumeFinal infarct volumeDWI stroke volumeInfarct core volume
02

Biological functions

Other (quantitative measurement of tissue damage after ischemic stroke)
03

Disease associations

Cardiovascular disease (specifically ischemic stroke)Neurodegenerative disease (as a consequence of large cerebral infarcts)
04

Safety considerations

Not applicable to the concept itself; however, larger infarct volumes are associated with worse clinical outcomes and higher risk of complications such as brain edema and hemorrhagic transformation[1][2].
05

Biomarkers

MRI diffusion-weighted imaging lesion sizeCT perfusion core sizeASPECTS score as surrogate for large/small infarcts[1][2][5][6]

Beyond the preview

Go deeper on Infarct volume (None).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Infarct volume (None).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call